SABA ZABARAH: Open Payments
NPI 1598265886 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 15 payments from 8 companies in 2025. Trend: 2023 $1,034 · 2024 $355 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| ABBVIE INC. | 2 | $63 |
| Lilly USA, LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Novo Nordisk Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
Products named: Kerendia, MOUNJARO, BOTOX, QULIPTA, AIRSUPRA, Ozempic, TRINTELLIX, YUPELRI.
Industry payments across TX — which companies pay providers there.
